SEC Filings
BridgeBio's Operating Loss Shrinks To $11.6 Million As Attruby Sales Climb, With Three FDA Dates Ahead
A $75.0 million Bayer milestone and Attruby growth cut the loss; the company has $1.5 billion in cash and FDA dates from November to May.